Prestige Consumer Healthcare Inc. (PBH): Price and Financial Metrics
Prestige Consumer Healthcare Inc. (PBH)
Today's Latest Price: $38.08 USD
Updated Jan 22 7:00pm
Add PBH to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 77 in Medical - Services
See all "A" rated Strong Buy stocks
PBH Stock Summary
- For PBH, its debt to operating expenses ratio is greater than that reported by 85.44% of US equities we're observing.
- Over the past twelve months, PBH has reported earnings growth of 372.71%, putting it ahead of 96.02% of US stocks in our set.
- The volatility of Prestige Consumer Healthcare Inc's share price is greater than that of merely 5.4% US stocks with at least 200 days of trading history.
- If you're looking for stocks that are quantitatively similar to Prestige Consumer Healthcare Inc, a group of peers worth examining would be TGNA, ECPG, HRI, OSN, and CLW.
- Visit PBH's SEC page to see the company's official filings. To visit the company's web site, go to www.prestigebrands.com.
PBH Stock Price Chart Interactive Chart >
PBH Price/Volume Stats
| Current price | $38.08 | 52-week high | $46.12 |
| Prev. close | $37.95 | 52-week low | $27.40 |
| Day low | $37.35 | Volume | 249,300 |
| Day high | $38.13 | Avg. volume | 340,300 |
| 50-day MA | $36.37 | Dividend yield | N/A |
| 200-day MA | $37.53 | Market Cap | 1.91B |
Prestige Consumer Healthcare Inc. (PBH) Company Bio
Prestige Brands Holdings markets and distributes brand name over-the-counter health-care and household products throughout the U.S., Canada, Australia, and in certain other international markets. Core brands include Monistat women's health products, Nix lice treatments, Chloraseptic sore throat treatments, Compound W wart treatments, Clear Eyes eye care products, Little Remedies pediatric products, The Doctor's NightGuard dental protector, Efferdent denture care products, Luden's throat drops, Dramamine motion sickness treatments, BC and Goody's headache remedies, Beano gas prevention, Debrox earwax remover, and in Canada, Gaviscon antacid. The company was founded in 1996 and is based in Tarrytown, New York.
PBH Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $38.08 | $50.92 | 34% |
Below please find a table outlining a discounted cash flow forecast for PBH, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Prestige Consumer Healthcare Inc ranked in the 58th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 34.83% on a DCF basis. The most interesting components of our discounted cash flow analysis for Prestige Consumer Healthcare Inc ended up being:
- 55% of the company's capital comes from equity, which is greater than just 23.89% of stocks in our cash flow based forecasting set.
- Prestige Consumer Healthcare Inc's weighted average cost of capital (WACC) is 8%; for context, that number is higher than merely 8.13% of tickers in our DCF set.
- Relative to other stocks in its sector (Healthcare), Prestige Consumer Healthcare Inc has a reliance on debt greater than 86.74% of them.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 32% |
| 1% | 33% |
| 2% | 34% |
| 3% | 35% |
| 4% | 37% |
| 5% | 38% |
Want more companies with a valuation profile/forecast similar to that of Prestige Consumer Healthcare Inc? See HBIO, JAZZ, HRC, UTHR, and CHE.
Loading social stream, please wait...